Small molecule and Oligonucleotide DMPK In Vitro Scientist

The Glaxo Smith Kline team is seeking an experienced and talented Small Molecule and Oligonucleotide DMPK In Vitro Scientist to join our dynamic group. This position offers a unique opportunity to work with a leading team in the development and execution of DMPK and pharmacology studies for small molecules and oligonucleotides in drug discovery and development. The successful candidate will be a creative and driven individual with excellent scientific and organizational skills, as well as a proven track record of success in the field.The ideal candidate should possess a PhD in a relevant scientific discipline, as well as experience with in vitro pharmacology and DMPK assays. Expertise in cell-based assays and demonstrated success in the design, execution, and interpretation of experiments with small molecules and oligonucleotides is also highly desirable. Furthermore, the successful candidate should have strong communication and collaboration skills, as well as excellent problem-solving abilities.

According to JobzMall, the average salary range for a Small molecule and Oligonucleotide DMPK In Vitro Scientist in Collegeville, PA 19426, USA is $81,000 - $120,000 per year. This salary range takes into consideration the experience of the candidate, the company, and other factors.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.